PH

Phillip Hains

Chimeric Therapeutics Limited | Non-Executive Director, Interim Chairman
Mr Hains is a Chartered Accountant with more than 30 years experience providing businesses with accounting, administration, compliance and general management services. Until February 2026, he operated a specialist CFO Services division of Acclime Australia. A specialist in the public company environment, he has advised and supported a number of company boards and their related committees. He now focuses on non-executive director roles. He served as a non-executive director of Radiopharm Theranostics Limited from March 2024 to November 2025 and is currently a non-executive director of Chimeric Therapeutics Limited, a position he has held since July 2023, and Frontier Digital Ventures Limited, since October 2025.

Companies and Roles

Company
Title
Tenure
Since
CHM
CHM
Chimeric Therapeutics Limited
  • Non-Executive Director
  • Interim Chairman
7mthFeb 2026
FDV
FDV
Frontier Digital Ventures Limited
  • Interim Non-Executive Director,
11mthOct 2025
HXL
HXL
Hexima Limited
  • Non-Executive Director
3yrsSep 2023

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
FDV
FDV
Frontier Digital Ventures Limited
28/08/26095,238N/AN/A
RAD
RAD
30/06/25N/A15,956,63216,833,562N/A
CHM
CHM
Chimeric Therapeutics Limited
30/06/25N/A12,934,7242,608,696N/A
HXL
HXL
Hexima Limited
18/09/230N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
FDV
FDV
Frontier Digital Ventures Limited
28/08/26
Issued
95,238$0.340$32,380Director remuneration
CHM
CHM
Chimeric Therapeutics Limited
30/04/25
Issued
2,608,696$0.005$13,043Rights issue
CHM
CHM
Chimeric Therapeutics Limited
30/04/25
Issued
2,608,696$0.005$13,043Rights issue
RAD
RAD
16/12/24
Issued
8,000,000$0.027$216,000Issue of options
RAD
RAD
13/09/24
Issued
4,850,000$0.030$145,500Placement